Recent evidence reveals that the dysregulated expression of plectin modulates the cellular and non-cellular architecture of the tumor microenvironment (TME), thereby facilitating a supportive niche for tumor invasion and dissemination. The gene discussed is PLEC; the disease is neoplasm.